Navigation Links
Georgia Physicians' Study Published in The Journal of Urology
Date:2/26/2013

ence of prostate cancer 25 years after this irradiation program.  To compare like populations, this study compares patients treated between 1984-2000 to two previous studies that looked at patients who had surgical radical prostatectomy. The 15 years of follow-up data for these three studies calculated disease-free survival (DFS) based on a PSA<0.2 ng/dl. The surgical definition is much stricter than the one usually used in radiation therapy studies.  Results of these three studies showed comparable DFS at 10 (75 percent, 77 percent and 77 percent) and 15 years of follow-up (73 percent, 68 percent and 75 percent) respectively, showing that prostatectomy and the combination of seed implant followed by external beam radiation therapy are equally effective.  A sub analysis of patients treated with transperineal implants and external beam radiation therapy between 1995 and 2000 in our study showed a 15-year disease-free survival of 79 percent.

A secondary analysis in this publication includes over 300 men treated 16-25 years ago whose prostate cancer recurred after treatment.  Recurrences were PSA defined and results showed the majority of recurrences happened within the first five years after treatment and no recurrences 15.5-25 years after treatment.  This is the first to include interval censoring analysis when looking at time to recurrence. 

This study concludes that follow-ups are necessary for 15 years after treatment to fully evaluate any treatment for prostate cancer. If a man's PSA is <0.20 ng/ml 15 years post treatment, later recurrence of the disease should be rare. For more information, visit www.curingprostatecancer.com.

About Radiotherapy Clinics of Georgia
An affiliate of Vantage Oncology, Radiotherapy Clinics of Georgia was founded in 1982 and has earned
'/>"/>

SOURCE Radiotherapy Clinics of Georgia
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology news :

1. Physicians belief about obesity causes impacts advice and care
2. Scripps physicians call for change in cancer tissue handling
3. Physicians admit feeling under qualified and lacking necessary education to treat obesity
4. Young gamers offer insight to teaching new physicians robotic surgery
5. FirstMark Exhibiting and Presenting at the San Diego Academy of Family Physicians 55th Annual Postgraduate Symposium
6. New study shows continued decline in the last remaining stronghold for leatherback sea turtles
7. Study finds maize in diets of people in coastal Peru dates to 5,000 years ago
8. WCS Adirondack Park study shows exurban residences impact bird communities up to 200 meters away
9. Influenza study: Meet virus new enemy
10. Omega-3s inhibit breast cancer tumor growth, study finds
11. New study indicates avocado consumption may be associated with better diet quality
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2015)... MINNETONKA, Minn. , Feb. 12, 2015 /PRNewswire/ ... technology company specializing in clinical study management systems, ... Partner Program , further distinguishing iMedNet ... for Clinical Research Organizations (CROs) and healthcare consultants.  ... sales support, prospective customer referrals and numerous co-marketing ...
(Date:2/9/2015)... -- Lintec of America recently announced an exclusive license to ... including sheets, yarns and ribbons, developed at the University ... vast industrial resources of the global Lintec Group, headquartered ... America is forming the Nano-Science and Technology Center (NSTC) ... scaling up the manufacturing and commercialization of nano engineered ...
(Date:2/5/2015)... , Jan. 26, 2015 NXT-ID, Inc. (NASDAQ: ... a biometric authentication company focused on the growing mobile ... website ( http://www.nxt-id.com/ ) as part of its 2015 ... The Company launched its new consumer website for Wocketwallet.com ... , CEO of NXT-ID said, "Our new corporate website ...
Breaking Biology News(10 mins):MedNet Solutions Announces Key Enhancements To Its iMedNet Partner Program 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 2NXT-ID, Inc. Launches New Corporate Website As Part Of Ongoing 2015 Branding Initiatives For Wocket Smart Wallet 3
... far too much salt, and a University of Iowa researcher ... put us in a better mood. UI psychologist Kim ... are deficient in sodium chloride, common table salt, they shy ... substance or pressing a bar that stimulates a pleasant sensation ...
... states the case for protecting the species in ... , recently published by Harvard University Press. ... Bianca Perla, a University of Washington ecologist, and Jennifer ... New York in Stony Brook, shows that animals are ...
... at Children,s National Medical Center have identified ... suffering from sepsis: platelets. The finding, published ... Care Medicine , is the first time doctors have ... this often fatal infection. "Despite many medical ...
Cached Biology News:Study suggests salt might be 'nature's antidepressant' 2Study suggests salt might be 'nature's antidepressant' 3Prairie dog research promotes caring, conservation 2Children's National research links platelets to sepsis-related organ failure 2
(Date:3/4/2015)... California (PRWEB) March 04, 2015 ... (PCR) represents one of the fastest growing technologies in ... biologists in subcellular visualization is driving growth in nucleic ... for deeper understanding of gene expressions will continue to ... Expanding applications in fields ranging from pharma, biotech, food ...
(Date:3/4/2015)... PARIS , March 4, 2015 ... Hopitaux de Paris en ... «   SARAH   », qui compare   ... l,yttrium-90 avec le   sorafénib dans le carcinome ... atteints d,un cancer du foie avancé   ; ...
(Date:3/3/2015)... DIEGO and TORONTO, March 3, 2015 /PRNewswire/ - Aptose ... developing new therapeutics and molecular diagnostics that target the ... the quarter and seventh-month period ended December 31, 2014. ... its fiscal year end from May 31 to December ... we are reporting today are for the quarter and ...
(Date:3/3/2015)... 2015 NASA astronaut Scott Kelly , who ... spend a year living and working on the International Space ... to 7 a.m. EDT Monday, March 9. Kelly ... completes the final weeks of his training. The interviews will ... Television highlighting his mission training and previous spaceflights. ...
Breaking Biology Technology:Focus on Quantifying Nucleic Acid Molecules Spurs Growth in the qPCR & dPCR Instrumentation Market, According to a New Report by Global Industry Analysts, Inc. 2Focus on Quantifying Nucleic Acid Molecules Spurs Growth in the qPCR & dPCR Instrumentation Market, According to a New Report by Global Industry Analysts, Inc. 3Focus on Quantifying Nucleic Acid Molecules Spurs Growth in the qPCR & dPCR Instrumentation Market, According to a New Report by Global Industry Analysts, Inc. 4Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 2Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 3Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 4Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 5Traitement du cancer primitif du foie : Recrutement terminé pour l'étude SARAH et résultats attendus fin 2016 6Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 2Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 3Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 4Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 5Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 6Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 7Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 8Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 9Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 10Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 11Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 12NASA Astronaut Scott Kelly Available for Interviews before One-Year Space Station Mission 2
... 20 Transdel Pharmaceuticals, Inc. (OTC Bulletin Board: TDLP), ... products using its proprietary transdermal delivery platform, today announced ... of Transdel, will present a company overview at ... the 4th annual BIOCOM Investor Conference in San Diego, ...
... ATLANTA, Oct. 20 GeoVax Labs, Inc. ... "Company"), an Atlanta-based, biopharmaceutical company developing human vaccines for ... infectious agents, today announced that it will move its ... of Emory University to Smyrna, Georgia, a northwest suburb ...
... ... ways to make organic gardening simple, safe and fun. , ... Boston, MA (PRWEB) October 19, 2009 -- It,s no longer ... naturally. As a matter of fact, "as the demand for healthy, fresh fruits and veggies ...
Cached Biology Technology:Transdel Pharmaceuticals to Present at Two Investor Conferences 2Transdel Pharmaceuticals to Present at Two Investor Conferences 3GeoVax Labs, Inc. Moving Operations to Smyrna, Georgia 2GeoVax Labs, Inc. Moving Operations to Smyrna, Georgia 3GeoVax Labs, Inc. Moving Operations to Smyrna, Georgia 4The Growing Demand for Organic Gardening Sprouts New Self Sustaining Innovations 2The Growing Demand for Organic Gardening Sprouts New Self Sustaining Innovations 3
Goat polyclonal to SPFH2 ( Abpromise for all tested applications). Antigen: Synthetic peptide: EDEPLETATKEN, corresponding to C terminal amino acids 328-339 of Human SPFH2 Entrez Gene ID: 11...
Goat polyclonal to Als2 ( Abpromise for all tested applications). entrezGeneID: 57679 SwissProtID: Q96Q42...
Anti-Kusabira Orange Monoclonal Antibody Description: 100 g Research Focus: tag Storage: -20C Shipping Temperature: 4C...
Anti-Kusabira Orange Monoclonal Antibody Description: 100 g Research Focus: tag Storage: -20C Shipping Temperature: 4C...
Biology Products: